PTC Therapeutics Inc (PTCT)
45.23
-0.61
(-1.33%)
USD |
NASDAQ |
Dec 27, 16:00
45.11
-0.12
(-0.27%)
After-Hours: 20:00
PTC Therapeutics SG&A Expense (Quarterly): 73.46M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 371.80M |
| ClearPoint Neuro Inc | 6.704M |
| Pfizer Inc | 3.244B |
| Blueprint Medicines Corp | 89.93M |
| BridgeBio Pharma Inc | 68.82M |